ASPR, Regeneron Expand Existing Collaboration to Develop 2019-nCoV Treatment

[advanced_iframe securitykey=”undefined” src=”https://view.connect.hhs.gov/?qs=6d9bd620d49bd5a41ea725c918a16da38556bd1fbe20421c2a062787093160eb0c4c73df3b951f2351f5ef23bf950e809c0ca25107ad1ce89b51345aa2c86c2569e9f69c1afd9610″ width=”100%” height=”2500″]